SHUFRO ROSE & CO LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHUFRO ROSE & CO LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2019$32,000
+45.5%
10,0000.0%0.00%
+50.0%
Q3 2019$22,000
-29.0%
10,0000.0%0.00%
-33.3%
Q2 2019$31,000
-16.2%
10,0000.0%0.00%
-25.0%
Q1 2019$37,000
+12.1%
10,000
-13.0%
0.00%0.0%
Q4 2018$33,000
+10.0%
11,5000.0%0.00%
+33.3%
Q3 2018$30,000
+11.1%
11,5000.0%0.00%0.0%
Q2 2018$27,000
-20.6%
11,5000.0%0.00%0.0%
Q1 2018$34,000
+6.2%
11,5000.0%0.00%0.0%
Q4 2017$32,000
-17.9%
11,5000.0%0.00%
-25.0%
Q3 2017$39,000
+39.3%
11,5000.0%0.00%
+33.3%
Q2 2017$28,000
+7.7%
11,5000.0%0.00%0.0%
Q1 2017$26,00011,5000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders